» Articles » PMID: 35355424

Circ_ZFR Affects FABP7 Expression to Regulate Breast Cancer Progression by Acting As a Sponge for MiR-223-3p

Overview
Journal Thorac Cancer
Date 2022 Mar 31
PMID 35355424
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Breast cancer (BC) is a common malignancy in women. Circular RNAs (circRNAs) have been reported to play a key role in the development of BC; however, the effect of circular RNA zinc finger RNA binding protein (circ_ZFR) in BC is unknown.

Methods: Abundances of circ_ZFR, fatty acid binding protein 7 (FABP7), and microRNA-223-3p (miR-223-3p) were measured by quantitative real-time polymerase chain reaction (qRT-PCR). The circular structure of circ_ZFR was validated by RNase R treatment. Cell proliferation, migration, invasion, and apoptosis were assessed by colony formation, cell counting kit-8, Transwell, flow cytometry assays, respectively. All protein levels were determined by Western blot. Dual-luciferase reporter assay was used to confirm the relationship between miR-223-3p and circ_ZFR or FABP7. A xenograft model was established to understand the effect of circ_ZFR on BC cell growth in vivo.

Results: The expression levels of circ_ZFR and FABP7 were higher in BC tissues and cell lines, whereas miR-223-3p expression was lower. Knockdown of circ_ZFR or FABP7 in BC cells reduced proliferation, migration, invasion, and epithelial mesenchymal transition (EMT), and induced apoptosis in vitro, whereas the opposite effects were observed in circ_ZFR-overexpressed cells. Furthermore, circ_ZFR might act as a sponge for miR-223-3p to regulate FABP7 expression, thereby promoting the progression of BC cells in vitro and in vivo.

Conclusion: Circ_ZFR might act as a miRNA sponge for miR-223-3p to regulate FABP7, thereby promoting proliferation, migration, invasion, and EMT of BC cells, and inhibiting cell apoptosis.

Citing Articles

MiR-223-3p in Cancer Development and Cancer Drug Resistance: Same Coin, Different Faces.

Barbagallo D, Ponti D, Bassani B, Bruno A, Pulze L, Akkihal S Int J Mol Sci. 2024; 25(15).

PMID: 39125761 PMC: 11311375. DOI: 10.3390/ijms25158191.


Integrating molecular pathway with genome-wide association data for causality identification in breast cancer.

Li Y, Jiang H Discov Oncol. 2024; 15(1):254.

PMID: 38954227 PMC: 11219684. DOI: 10.1007/s12672-024-01125-7.


Metabolism-regulating non-coding RNAs in breast cancer: roles, mechanisms and clinical applications.

Xu S, Wang L, Zhao Y, Mo T, Wang B, Lin J J Biomed Sci. 2024; 31(1):25.

PMID: 38408962 PMC: 10895768. DOI: 10.1186/s12929-024-01013-w.


Circular RNA and its potential diagnostic and therapeutic values in breast cancer.

Gao D, Cui C, Jiao Y, Zhang H, Li M, Wang J Mol Biol Rep. 2024; 51(1):258.

PMID: 38302635 DOI: 10.1007/s11033-023-09172-z.


Circular RNA-mediated miRNA sponge & RNA binding protein in biological modulation of breast cancer.

Zhu J, Li Q, Wu Z, Xu W, Jiang R Noncoding RNA Res. 2024; 9(1):262-276.

PMID: 38282696 PMC: 10818160. DOI: 10.1016/j.ncrna.2023.12.005.


References
1.
Zhang W, Liu Q, Wang T, Zhao J, Cheng X, Wang J . CircZFR serves as a prognostic marker to promote bladder cancer progression by regulating miR-377/ZEB2 signaling. Biosci Rep. 2019; 39(12). PMC: 6893170. DOI: 10.1042/BSR20192779. View

2.
Chen L . The biogenesis and emerging roles of circular RNAs. Nat Rev Mol Cell Biol. 2016; 17(4):205-11. DOI: 10.1038/nrm.2015.32. View

3.
Tan A, Li Q, Chen L . CircZFR promotes hepatocellular carcinoma progression through regulating miR-3619-5p/CTNNB1 axis and activating Wnt/β-catenin pathway. Arch Biochem Biophys. 2018; 661:196-202. DOI: 10.1016/j.abb.2018.11.020. View

4.
Chen Z, Wang F, Xiong Y, Wang N, Gu Y, Qiu X . CircZFR functions as a sponge of miR-578 to promote breast cancer progression by regulating HIF1A expression. Cancer Cell Int. 2020; 20:400. PMC: 7437024. DOI: 10.1186/s12935-020-01492-5. View

5.
Sun Y, Zhou Y, Shi X, Ma X, Peng X, Xie Y . CircTYW1 serves as a sponge for microRNA-380 in accelerating neurological recovery following spinal cord injury via regulating FGF9. Cell Cycle. 2021; 20(18):1828-1844. PMC: 8525943. DOI: 10.1080/15384101.2021.1962634. View